Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Qiagen to Distribute Altona Diagnostic’s Ebola Tests

by Global Biodefense Staff
December 8, 2014
Ebola Virus Outbreak

Scanning electron micrograph of Ebola virus budding from the surface of a Vero cell (African green monkey kidney epithelial cell line. Credit: NIAID

QIAGEN recently announced it will offer global distribution of the RealStar Ebolavirus RT-PCR Kit.

The diagnostic kit, developed and manufactured by altona Diagnostics GmbH, is a reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of RNA from all known strains of Ebolaviruses, including the Zaire strain driving the current Ebola epidemic in West Africa.

QIAGEN agreed to distribute the tests after an existing Emergency Use Authorization (EUA) for the kits was modified on Nov. 26 by the U.S. Food and Drug Administration to permit authorized distribution and use in US and certain non-US laboratories.

The RealStar Ebolavirus kit is authorized for emergency use on specified instruments in plasma from individuals with signs and symptoms of Ebolavirus infection in conjunction with clinical and epidemiological risk factors. The EAU provides for use of the kit by CLIA High Complexity Laboratories and similarly qualified non-U.S. laboratories and only for the detection – not differentiation – of RNA from Ebolaviruses such as Zaire ebolavirus, including the Zaire ebolavirus strain detected in the West Africa outbreak 2014.

QIAGEN’s latest agreement with altona Diagnostics expands an existing collaboration between the two companies which was signed in the third quarter of 2014. Under this earlier agreement, QIAGEN is also distributing the RealStar Filovirus RT-PCR Kit, which does not fall under the EUA. This test is for both Ebola and Marburg and is CE-IVD marked for use on QIAGEN instruments and with QIAGEN sample technologies outside the United States.

Source: QIAGEN press release, adapted. RealStar is a registered, protected term of altona Diagnostics.

Tags: EbolaEmergency Use AuthorizationMarburg

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy